In contrast to co-treatment with GLP-1GIP plus Lani, the GLP-1GIPLani conjugate also fully prevented body weight gain in obesity-prone leptin receptor-deficient db/db mice (Extended Data Fig
Series B, Containing Papers of a Biological Character , 111/769, pp
Nutrition and exercise interventions to improve body composition for persons with overweight or obesity near retirement age: a systematic review and network meta-analysis of randomized controlled trials
Adherence to antihypertensive medication in treatment-resistant hypertension undergoing renal denervation
Avoid drinking alcohol while on Contrave, as the combination can increase the risk of serious side effects like seizures, neuropsychiatric adverse effects, and liver injury
While GEP-44 remains in preclinical development, these early findings position SureNano Science within a highly strategic segment of the obesity treatment landscape